Filipov, A.; Fuchshuber, H.; Kraus, J.; Ebert, A.D.; Sandikci, V.; Alonso, A.
Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus. J. Clin. Med. 2022, 11, 1625.
https://doi.org/10.3390/jcm11061625
AMA Style
Filipov A, Fuchshuber H, Kraus J, Ebert AD, Sandikci V, Alonso A.
Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus. Journal of Clinical Medicine. 2022; 11(6):1625.
https://doi.org/10.3390/jcm11061625
Chicago/Turabian Style
Filipov, Alexandra, Heike Fuchshuber, Josephine Kraus, Anne D. Ebert, Vesile Sandikci, and Angelika Alonso.
2022. "Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus" Journal of Clinical Medicine 11, no. 6: 1625.
https://doi.org/10.3390/jcm11061625
APA Style
Filipov, A., Fuchshuber, H., Kraus, J., Ebert, A. D., Sandikci, V., & Alonso, A.
(2022). Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus. Journal of Clinical Medicine, 11(6), 1625.
https://doi.org/10.3390/jcm11061625